GlassScriptPhysician profile
Martina Dockery Monroe
NPI 1699779454
$2,519.43
in general payments reported to CMS, 2019-2025
16 companies · $1,322 in 2025
The $1,322 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,198 · 2025: $1,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,519.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $708.45 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $368.71 | 2024-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $337.58 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $316.89 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $277.57 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.88 | 2024-2025 | Jardiance |
| Corcept Therapeutics | $89.83 | 2024-2025 | Korlym |
| Abbvie INC. | $76.52 | 2025 | |
| Exact Sciences Corporation | $66.18 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Radius Health, INC. | $49.58 | 2025 | Tymlos |
| Amgen INC. | $38.03 | 2024-2025 | Repatha, Repatha, Otezla |
| Medtronic, INC. | $24.63 | 2025 | Inceptiv |
| Phathom Pharmaceuticals, INC. | $23.40 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $21.49 | 2025 | |
| Novartis Pharmaceuticals Corporation | $15.70 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.99 | 2024 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martina Monroe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.